Fusion Capital Management Partners with Burney Company as Outsourced Chief Investment Officer, Leveraging 50 Years of U.S. Equity Management Expertise
Tech-enabled RIA selects proven investment partner to bolster advisor capabilities and improve client outcomes DALLAS and RESTON, Va., June 10, 2025 /PRNewswire/... Read more.
ActiveCampaign Taps Chai Atreya as Chief Product Officer to Advance Industry-Leading Autonomous Marketing Automation
Former Alteryx and Amazon leader brings deep product expertise to spearhead product vision, driving the company’s innovation in autonomous marketing orchestration... Read more.
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture... Read more.
P3F at the G7 Summit with an AI innovation in aviation safety
BLAINVILLE, QC, June 10, 2025 /CNW/ – P3F is proud to announce that one of its projects, developed in collaboration with Mila, Nolinor Aviation, CIRRUS Intelligence... Read more.
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ST. PAUL, Minn., June 10, 2025 /PRNewswire/ — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced... Read more.
Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
ADCE-D01 is a first-in-class antibody-drug conjugate (ADC) targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple... Read more.
An AI solution from CIRRUS Intelligence showcased at the G7
MIRABEL, QC, June 10, 2025 /CNW/ – CIRRUS Intelligence is proud to announce that its groundbreaking aviation safety solution, developed in collaboration with Nolinor... Read more.
DeepCure Announces DC-15442 as Development Candidate, an Oral STAT6 Inhibitor with 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilumab across disease models
DC-15442 is a potent small molecule STAT6 inhibitor, which is not a degrader or prodrug, being advanced as a safe dupilumab-in-a-pill alternative for patients BOSTON,... Read more.
NABR Recognizes Signature Bank as One of Chicago’s Best and Brightest Companies to Work For® Eighth Year in a Row
Bank receives high marks from employees for supporting their growth and development, trustworthy leadership team, mutual respect among teams ROSEMONT, Ill., June... Read more.
International Wire Group Acquires Hussey Copper
STAMFORD, Conn., June 10, 2025 /PRNewswire/ — International Wire Group (IWG), a portfolio company of Olympus Partners and Atlas Holdings, entered into a definitive... Read more.